Germany's BioNTech Should Be Able to Adapt Its Coronavirus Vaccine Relatively Quickly in ... - Latest Tweet by Reuters

Germany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, its CEO Ugur Sahin said in an interview during the #ReutersNext conference https://t.co/11ueEXykW7 pic.twitter.com/CHxF961ztW— Reuters (@Reuters) December 3, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)